🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted to assess any potential differences in the ab...
Status
Completed
Location
West Coast Clinical Trials, LLC
Start Date
2009-01-28
Trial ID
NCT00880750
Treatments Being Tested
An open-label, drug-drug interaction study with TPOXX and phosphate binders...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2022-06-08
Trial ID
NCT04485039
This study is a regulatory post marketing surveillance in Japan, and it is ...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-07
Trial ID
NCT01412398
Treatments Being Tested
Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphat...
Status
Terminated
Location
Nephrology Associates PC
Start Date
2009-07
Trial ID
NCT00841126
Treatments Being Tested
To assess the effects of 12 weeks of treatment with lanthanum carbonate com...
Status
Completed
Location
Dr Pablo Urena Torres
Start Date
2010-12-06
Trial ID
NCT01128179
Treatments Being Tested
The study is conducted as a randomized, non-blinded, 2-way crossover study....
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01053676
To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hyd...
Status
Completed
Location
DSI Renal Inc.
Start Date
2007-01-05
Trial ID
NCT00441545
Treatments Being Tested
The primary objective of this study was to establish the bioequivalence of ...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-10
Trial ID
NCT03074058
This study is a regulatory post marketing surveillance in Japan, and it is ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-23
Trial ID
NCT01419327
Treatments Being Tested
Patients with end-stage renal disease (ESRD) commonly develop hyperphosphat...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2008-01
Trial ID
NCT00660530
Treatments Being Tested